Ikuma Mutsuhiro

イクマムツヒロ | Ikuma Mutsuhiro

Affiliation and department：

Research field (2)： Gastroenterology , Internal medicine - General

Research keywords (5)：薬剤疫学 , 消化器病学 , Cell Biology , Physiology , Gastroenterology

Research theme for competitive and other funds (10)：

2008 - 2011 グリア細胞系による消化管粘膜免疫の調節
2001 - 2011 消化器病態生理学
2001 - 2011 Gastroenterology
2008 - 2010 Development of genomics-based prophylaxis strategy for NSIAD ulcer
2008 - 2009 スタチンの新たな効果:消化管粘膜免疫への関与

Show all

Papers (44)：

Mototsugu Tanaka, Haruna Miyazawa, Ryohei Terashima, Mutsuhiro Ikuma. Conditional early approval for new drug applications in Japan: Current and emerging issues. Clinical and translational science. 2023. 16. 8. 1289-1293
Mototsugu Tanaka, Mutsuhiro Ikuma, Wataru Asakura, Yasuhiro Fujiwara. The PMDA Perspectives on New Oral Prolyl Hydroxylase Domain Enzyme Inhibitors for Renal Anemia. Clinical Pharmacology & Therapeutics. 2022. 111. 2. 358-361
Shinobu Uzu, Shohko Sekine, Junichi Asano, Mutsuhiro Ikuma. Assessment of the impact of Japanese-specific long-term safety data on new drug approval. Clinical and Translational Science. 2021. 14. 6. 2339-2347
Mototsugu Tanaka, Mayumi Idei, Hiroshi Sakaguchi, Ryosuke Kato, Daisuke Sato, Kenji Sawanobori, Shuichi Kawarasaki, Toshiyuki Hata, Asako Yoshizaki, Miki Nakamura, et al. Achievements and challenges of the Sakigake designation system in Japan. British Journal of Clinical Pharmacology. 2021. 87. 10. 4027-4035
Mototsugu Tanaka, Mayumi Idei, Hiroshi Sakaguchi, Ryosuke Kato, Daisuke Sato, Kenji Sawanobori, Shuichi Kawarasaki, Toshiyuki Hata, Asako Yoshizaki, Miki Nakamura, et al. Rationales of delay and difference in regulatory review by Japan, the USA and Europe among new drugs first approved in Japan. British Journal of Clinical Pharmacology. 2021. 87. 8. 3279-3291

ｍore...

MISC (53)：

Masafumi Nishino, Mitsushige Sugimoto, Chise Kodaira, Mihoko Yamade, Takahiro Uotani, Naohito Shirai, Mutsuhiro Ikuma, Tatsuo Tanaka, Haruhiko Sugimura, Akira Hishida, et al. Preventive Effects of Lansoprazole and Famotidine on Gastric Mucosal Injury Induced by Low-Dose Aspirin in Helicobacter pylori-Negative Healthy Volunteers. JOURNAL OF CLINICAL PHARMACOLOGY. 2011. 51. 7. 1079-1086
Takahisa Furuta, Mitsushige Sugimoto, Chise Kodaira, Masafumi Nishino, Mihoko Yamade, Takahiro Uotani, Mutsuhiro Ikuma, Hiroshi Watanabe, Kazuo Umemura. Efficacy of Genetics-Based Regimens for Eradicating of Helicobacter pylori Infections. GASTROENTEROLOGY. 2011. 140. 5. S58-S58
Shigeru Kanaoka, Yasushi Hamaya, Shigeru Kuriyama, Mutsuhiro Ikuma, Hiroaki Mlyajima. Alteration in Fecal COX-2 mRNA Expressions Before and After Surgical or Endoscopic Resection of Colorectal Cancer and Adenoma. GASTROENTEROLOGY. 2011. 140. 5. S337-S337
Takahiro Uotani, Mitsushige Sugimoto, Masafumi Nishino, Chise Kodaira, Mihoko Yamade, Mutsuhiro Ikuma, Takahisa Furuta. Rabeprazole Prevents Gastric Mucosal Injury Induced by Low-Dose Aspirin and Clopidogrel. GASTROENTEROLOGY. 2011. 140. 5. S587-S587
Yasuhiro Takayanagi, Satoshi Osawa, Takanori Yamada, Mutsuhiro Ikuma. Norepinephrine Suppresses the THI-Type Cytokines Production of Murine Intestinal Intraepithelial Lymphocytes via beta 1-Adrenoreceptor. GASTROENTEROLOGY. 2011. 140. 5. S839-S839

ｍore...

Education (4)：

- 1995 Hamamatsu University School of Medicine
- 1995 Hamamatsu University School of Medicine Graduate School, Division of Medicine
- 1986 Hamamatsu University School of Medicine Faculty of Medicine School of Medicine
- 1986 Hamamatsu University School of Medicine

Professional career (1)：

Doctor of Medical Science (Hamamatsu University School of Medicine)

Association Membership(s) (8)：

米国内科学会 , 米国消化器病学会 , 日本消化器内視鏡学会 , 日本消化器病学会 , 日本内科学会 , American College of Physicians , American Physiological Society , American Gastroenterology Association

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page